Novel inhibitors induce large conformational changes of GAB1 pleckstrin homology domain and kill breast cancer cells.
The Grb2-associated binding protein 1 (GAB1) integrates signals from different signaling pathways and is over-expressed in many cancers, therefore representing a new therapeutic target. In the present study, we aim to target the pleckstrin homology (PH) domain of GAB1 for cancer treatment. Using hom...
Main Authors: | , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2015-01-01
|
Series: | PLoS Computational Biology |
Online Access: | http://europepmc.org/articles/PMC4287437?pdf=render |